Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
104.38B | 108.28B | 92.64B | 76.90B | 80.25B | Gross Profit |
31.16B | 33.73B | 29.14B | 23.98B | 25.69B | EBIT |
11.05B | 12.75B | 9.73B | 7.22B | 7.76B | EBITDA |
15.71B | 16.89B | 13.52B | 10.73B | 11.70B | Net Income Common Stockholders |
8.67B | 8.53B | 6.31B | 4.54B | 6.29B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
42.45B | 46.90B | 48.75B | 47.62B | 42.51B | Total Assets |
140.78B | 135.36B | 122.58B | 108.21B | 105.38B | Total Debt |
0.00 | 490.00M | 0.00 | 0.00 | 0.00 | Net Debt |
-42.45B | -46.41B | -48.75B | -47.62B | -42.51B | Total Liabilities |
27.81B | 30.24B | 28.24B | 21.54B | 20.84B | Stockholders Equity |
112.97B | 105.13B | 94.33B | 86.68B | 84.54B |
Cash Flow | Free Cash Flow | |||
-2.96B | -1.81B | 5.19B | 7.86B | 2.73B | Operating Cash Flow |
11.97B | 9.12B | 9.76B | 10.64B | 7.69B | Investing Cash Flow |
-12.31B | -11.20B | -9.66B | -3.74B | -4.63B | Financing Cash Flow |
-4.15B | -2.50B | -2.36B | -1.69B | -1.81B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥1.03T | 12.49 | 10.10% | 3.13% | 3.28% | 6.56% | |
73 Outperform | ¥117.54B | 12.41 | 3.58% | 5.94% | 9.00% | ||
72 Outperform | $275.53B | 10.97 | 7.16% | 4.75% | 10.04% | -13.43% | |
67 Neutral | $1.00T | 13.35 | 4.16% | 5.04% | <0.01% | -58.95% | |
64 Neutral | $602.92B | 11.93 | 5.83% | 4.49% | 5.15% | -8.48% | |
49 Neutral | $1.96B | -1.23 | -21.20% | 3.72% | 0.88% | -29.24% | |
45 Neutral | ¥202.64B | 11.14 | -2.54% | 5.02% | 7.76% | -171.50% |